APIXAZEN 2.5mg: A Reliable Anticoagulant for Blood Clot Prevention

Apr 01, 2025


APIXAZEN 2.5 is an advanced anticoagulant medication formulated to prevent and manage blood clot-related conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke in individuals with atrial fibrillation (AF). Its key active ingredient, Apixaban (2.5mg), is a direct oral anticoagulant (DOAC) that works by blocking Factor Xa, a crucial enzyme in the blood clotting process. By inhibiting clot formation, APIXAZEN 2.5 significantly lowers the risk of serious cardiovascular complications, supporting long-term heart and vascular health.

Key Ingredient and Mechanism of Action

Apixaban (2.5mg) – A selective Factor Xa inhibitor that prevents the conversion of prothrombin to thrombin, an essential step in clot formation. By interrupting this pathway, Apixaban helps reduce the chances of abnormal clot development, lowering the risk of DVT, PE, and stroke in at-risk individuals.

Usage and Dosage

APIXAZEN 2.5 is taken orally, typically at a dosage of 2.5 mg twice daily, with or without food. Adhering to the prescribed regimen is crucial for optimal effectiveness. It is commonly used for:

✔ Stroke and systemic embolism prevention in patients with non-valvular atrial fibrillation (AF)

✔ Treatment and prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE)

✔ DVT prevention after knee or hip replacement surgery

Since Apixaban increases bleeding risk, patients should undergo regular monitoring for any signs of excessive bleeding or complications.

Key Benefits of APIXAZEN 2.5

✔ Reduces Stroke Risk: Effectively lowers the risk of stroke and embolism in patients with AF.

✔ Prevents Blood Clots: Helps prevent and treat DVT and PE, reducing the risk of life-threatening complications.

✔ Easy to Use: Unlike older anticoagulants, APIXAZEN 2.5 does not require frequent blood monitoring, making it a convenient choice for patients.

✔ Fewer Drug and Food Interactions: Offers a safer and more manageable treatment option compared to traditional anticoagulants.

✔ Long-Term Protection: Effectively prevents recurrent clots, ensuring sustained cardiovascular health.

Conclusion

APIXAZEN 2.5 is a trusted and effective anticoagulant therapy that safeguards individuals from stroke, DVT, PE, and other clot-related conditions. With Apixaban (2.5mg) as its active ingredient, it provides a safe, convenient, and reliable solution for preventing blood clots and improving overall cardiovascular well-being. If you're at risk of clot-related complications, consult your healthcare provider to determine if APIXAZEN 2.5 is the right choice for you.

About Steris Healthcare

Established in February 2018, Steris Healthcare Pvt Ltd (Sterispharma) is headquartered in Navi Mumbai and holds WHO, GMP, and ISO certifications, ensuring high standards of safety and quality. The company is committed to delivering affordable, high-quality medications across India, strictly following WHO guidelines.

Sterispharma provides a wide range of healthcare solutions covering Cardiology, Respiratory Care, Diabetes, Gastroenterology, Orthopedics, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dermatology, and more. Medications can be conveniently ordered online via Sterisonline, Sterisindia, and Sterispharma, with home delivery options available.

Contact Information

 

SHARE WITH